[go: up one dir, main page]

AU2002212187A1 - Diagnosis of illnesses or predisposition to certain illnesses - Google Patents

Diagnosis of illnesses or predisposition to certain illnesses

Info

Publication number
AU2002212187A1
AU2002212187A1 AU2002212187A AU1218702A AU2002212187A1 AU 2002212187 A1 AU2002212187 A1 AU 2002212187A1 AU 2002212187 A AU2002212187 A AU 2002212187A AU 1218702 A AU1218702 A AU 1218702A AU 2002212187 A1 AU2002212187 A1 AU 2002212187A1
Authority
AU
Australia
Prior art keywords
illnesses
predisposition
diagnosis
certain
certain illnesses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212187A
Inventor
Kurt Berlin
Alexander Olek
Christian Piepenbrock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epigenomics AG
Original Assignee
Epigenomics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epigenomics AG filed Critical Epigenomics AG
Publication of AU2002212187A1 publication Critical patent/AU2002212187A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82Translation products from oncogenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2002212187A 2000-09-01 2001-09-01 Diagnosis of illnesses or predisposition to certain illnesses Abandoned AU2002212187A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10043826.1 2000-09-01
DE10043826 2000-09-01
PCT/EP2001/010073 WO2002018631A2 (en) 2000-09-01 2001-09-01 Diagnosis of illnesses or predisposition to certain illnesses

Publications (1)

Publication Number Publication Date
AU2002212187A1 true AU2002212187A1 (en) 2002-03-13

Family

ID=7655132

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212187A Abandoned AU2002212187A1 (en) 2000-09-01 2001-09-01 Diagnosis of illnesses or predisposition to certain illnesses

Country Status (5)

Country Link
US (1) US20050064401A1 (en)
EP (1) EP1373564A2 (en)
JP (1) JP2005512499A (en)
AU (1) AU2002212187A1 (en)
WO (1) WO2002018631A2 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727230B1 (en) * 1994-03-25 2004-04-27 Coley Pharmaceutical Group, Inc. Immune stimulation by phosphorothioate oligonucleotide analogs
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US20030026782A1 (en) * 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
EP0855184A1 (en) * 1997-01-23 1998-07-29 Grayson B. Dr. Lipford Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
US6406705B1 (en) * 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
US6693086B1 (en) * 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
US20030022854A1 (en) 1998-06-25 2003-01-30 Dow Steven W. Vaccines using nucleic acid-lipid complexes
US7585847B2 (en) 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
US20040131628A1 (en) * 2000-03-08 2004-07-08 Bratzler Robert L. Nucleic acids for the treatment of disorders associated with microorganisms
KR100917101B1 (en) * 2000-08-04 2009-09-15 도요 보세키 가부시키가이샤 Flexible metal laminate and production method thereof
US7569553B2 (en) * 2002-07-03 2009-08-04 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US7605138B2 (en) * 2002-07-03 2009-10-20 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US20040053880A1 (en) * 2002-07-03 2004-03-18 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US7576066B2 (en) * 2002-07-03 2009-08-18 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US7807803B2 (en) * 2002-07-03 2010-10-05 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
AU2003257587A1 (en) * 2002-08-23 2004-03-11 Japan As Represented By President Of National Cancer Center Method of evaluating degree of canceration of human-origin specimen
DK2241325T3 (en) * 2002-10-29 2012-04-10 Coley Pharm Group Inc Use of CPG oligonucleotides to treat Hepatitis Cvirus infection
AU2003300919A1 (en) * 2002-12-11 2004-06-30 Coley Pharmaceutical Gmbh 5' cpg nucleic acids and methods of use
US8158768B2 (en) 2002-12-23 2012-04-17 Dynavax Technologies Corporation Immunostimulatory sequence oligonucleotides and methods of using the same
DK1575977T3 (en) * 2002-12-23 2009-11-09 Dynavax Tech Corp Immunostimulatory sequence oligonucleotides and methods for using them
AU2004226605A1 (en) * 2003-04-02 2004-10-14 Coley Pharmaceutical Group, Ltd. Immunostimulatory nucleic acid oil-in-water formulations for topical application
US20050013812A1 (en) * 2003-07-14 2005-01-20 Dow Steven W. Vaccines using pattern recognition receptor-ligand:lipid complexes
KR100558851B1 (en) * 2004-01-08 2006-03-10 학교법인연세대학교 CJ oligodeoxynucleotide variants with increased immunomodulatory capacity
ES2587068T3 (en) * 2006-04-17 2016-10-20 Epigenomics Ag Methods and nucleic acids for the detection of colorectal proliferative cell disorders
US8084734B2 (en) * 2006-05-26 2011-12-27 The George Washington University Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays
AU2008334901A1 (en) * 2007-12-11 2009-06-18 Epigenomics Ag Methods and nucleic acids for analyses of lung carcinoma
US20110117551A1 (en) * 2008-02-19 2011-05-19 Oncomethylome Sciences Sa Detection and prognosis of lung cancer
CA2736233A1 (en) * 2008-09-05 2010-03-11 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Predictive biomarkers
US8110796B2 (en) 2009-01-17 2012-02-07 The George Washington University Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays
US20120164238A1 (en) 2009-02-03 2012-06-28 Mdxhealth Sa Methods of detecting colorectal cancer
US9490113B2 (en) * 2009-04-07 2016-11-08 The George Washington University Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry
WO2010149782A1 (en) * 2009-06-26 2010-12-29 Epigenomics Ag Methods and nucleic acids for analysis of bladder cell proliferative disorders
US10752953B2 (en) 2011-05-12 2020-08-25 The Johns Hopkins University Method of detecting cancer through generalized loss of stability of epigenetic domains, and compositions thereof
GB201121924D0 (en) * 2011-12-20 2012-02-01 Fahy Gurteen Labs Ltd Detection of breast cancer
EP3230476B1 (en) 2014-12-12 2020-02-05 Exact Sciences Development Company, LLC Zdhhc1 for normalizing methylation detection assays
US10465248B2 (en) * 2014-12-12 2019-11-05 Exact Sciences Development Company, Llc Method of characterizing ZDHHC1 DNA
WO2016160454A1 (en) 2015-03-27 2016-10-06 Exact Sciences Corporation Detecting esophageal disorders
DE102015009187B3 (en) * 2015-07-16 2016-10-13 Dimo Dietrich Method for determining a mutation in genomic DNA, use of the method and kit for carrying out the method
DK3336197T3 (en) 2016-12-16 2022-07-11 Eurofins Genomics Europe Sequencing GmbH EPIGENETIC MARKERS AND RELATED METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF OVARIAN CANCER
CN111635938B (en) * 2020-04-30 2022-07-29 广州康立明生物科技股份有限公司 Tumor detection reagent and kit
CN111676287B (en) * 2020-06-03 2022-04-29 广州康立明生物科技股份有限公司 Gene marker combination and application thereof
CN112195243A (en) * 2020-09-22 2021-01-08 北京华大吉比爱生物技术有限公司 Kit for detecting polygene methylation and application thereof
EP4453245A2 (en) * 2021-12-23 2024-10-30 Mammoth Biosciences, Inc. Programmable nuclease-based assay improvements

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09507121A (en) * 1993-10-26 1997-07-22 アフィマックス テクノロジーズ ナームロゼ ベノートスハップ Nucleic acid probe array on biological chip
DE19754482A1 (en) * 1997-11-27 1999-07-01 Epigenomics Gmbh Process for making complex DNA methylation fingerprints

Also Published As

Publication number Publication date
JP2005512499A (en) 2005-05-12
WO2002018631A3 (en) 2003-10-16
WO2002018631A2 (en) 2002-03-07
EP1373564A2 (en) 2004-01-02
US20050064401A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
AU2002212187A1 (en) Diagnosis of illnesses or predisposition to certain illnesses
AUPR005600A0 (en) Diagnostic assay
GB0101989D0 (en) Improvements relating to information systems
AU2002239370A1 (en) Signal tampon
AU2002359659A1 (en) Cross reference to related application
AU4671401A (en) Bodily flow measuring system
AUPR605601A0 (en) Pipeite of sandwich construction
AU2001252367A1 (en) Improvements relating to computer systems
AU2001290093A1 (en) Clock
AU2002234169A1 (en) Measurement of electrophysiologic response
AU2002359986A1 (en) Period indicator
EP1126339A3 (en) Stopwatch
AU2001232105A1 (en) Improvements relating to data filtering
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002220913A1 (en) Improvements relating to thermometers
AU2001281123A1 (en) Haplotypes of the isl1 gene
AU2002222116A1 (en) Improvements relating to information systems
AU2001286890A1 (en) Haplotypes of the scya2 gene
AU2002216038A1 (en) Preparation of monofluoroalkenes
AU2001289288A1 (en) Improvements relating to information systems
AU2002342334A1 (en) Obtaining information to facilitate system usage
AU2002239511A1 (en) Haplotypes of the gsr gene
AU2002334465A1 (en) Improvement to instrumentation
GB9924457D0 (en) Improvements to the transmission of information
AU2001284319A1 (en) Improvements relating to information exchange systems

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application